Form 4 for AIM AIM ImmunoTech Inc.
Accepted 2021-07-16 00:00:00 ET · period of report 2021-07-16 · accession 0001450324-21-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-16 | 2021-07-16 | AIM | EQUELS THOMAS K. | CEO, Pres, Dir | P - Purchase | $1.92 | +15.6K | 225.3K | +7% | +$30.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-16 | P | A | 15,625 | $1.92 | 225,255 | D | — | — |